These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 22305792

  • 1. Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion.
    Zhang Y, Yu LK, Xia N.
    Asian Pac J Trop Med; 2012 Mar; 5(3):239-42. PubMed ID: 22305792
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C, Qian L, Yu L, Zhang X, Wang Q.
    Biomarkers; 2015 Mar; 20(4):271-4. PubMed ID: 26301886
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB, Bai M, Jin Y.
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J, Sun G, Zhu H.
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [Abstract] [Full Text] [Related]

  • 5. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H, Rona G, Hutter C, Bayer PM, Kummer F.
    Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811
    [Abstract] [Full Text] [Related]

  • 6. [Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1, TPS in the diagnosis of lung cancer].
    Huang F, Wang XL, Yang L, Yin BX, Geng Y, Li TT.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr 12; 24(4):370-2. PubMed ID: 18394347
    [Abstract] [Full Text] [Related]

  • 7. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M, Tamiya A, Yasue T, Nakao K, Omachi N, Shiroyama T, Tani E, Hamaguchi M, Morishita N, Suzuki H, Okamoto N, Okishio K, Kawaguchi T, Atagi S, Hirashima T.
    Anticancer Res; 2016 Jun 12; 36(6):2939-44. PubMed ID: 27272808
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
    Bao QL, Li J, Sun W, Jiang HG, Zhu LR, Wang Y.
    Jpn J Clin Oncol; 2014 Dec 12; 44(12):1198-205. PubMed ID: 25425729
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Values of sVEGFR-1 and Endostatin in Malignant Pleural Effusions in Patients with Lung Cancer.
    Zhu YY, Wu HM, Liu RY.
    Clin Lab; 2017 Sep 01; 63(9):1371-1378. PubMed ID: 28879702
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
    Zhang T, Liu W, Li L, Jue Z, Xu C.
    BMC Pulm Med; 2022 Aug 10; 22(1):307. PubMed ID: 35948914
    [Abstract] [Full Text] [Related]

  • 11. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F, Wei Y, Li LF, Li GL, Wang GJ.
    Zhonghua Zhong Liu Za Zhi; 2017 Jul 23; 39(7):524-527. PubMed ID: 28728299
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
    Jing X, Wei F, Li J, Dai L, Wang X, Jia L, Wang H, An L, Yang Y, Zhang G, Cheng Z.
    Clin Respir J; 2018 Mar 23; 12(3):986-990. PubMed ID: 28127951
    [Abstract] [Full Text] [Related]

  • 13. Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
    Chen Y, Liang B, Zhao YJ, Wang SC, Fan YB, Wu GP.
    Diagn Cytopathol; 2012 Apr 23; 40(4):287-91. PubMed ID: 22431315
    [Abstract] [Full Text] [Related]

  • 14. Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer.
    Zhang Y, Yu LK, Lu GJ, Xia N, Xie HY, Hu W, Hao KK, Xu CH, Qian Q.
    Asian Pac J Cancer Prev; 2014 Apr 23; 15(19):8435-40. PubMed ID: 25339042
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
    Xu CH, Hao KK, Yu LK, Zhang XW.
    Asia Pac J Clin Oncol; 2015 Mar 23; 11(1):28-33. PubMed ID: 24720371
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
    Jankowska R, Porebska I, Dyła T.
    Pneumonol Alergol Pol; 2002 Mar 23; 70(5-6):258-64. PubMed ID: 12518624
    [Abstract] [Full Text] [Related]

  • 17. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ, Zhang HL, Gao WJ, Lan X, Yuan BJ, Zou JM.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan 23; 26(1):34-8. PubMed ID: 18302890
    [Abstract] [Full Text] [Related]

  • 18. Pleural fluid carcinoembryonic antigen as a biomarker for the discrimination of tumor-related pleural effusion.
    Li H, Huang L, Tang H, Zhong N, He J.
    Clin Respir J; 2017 Nov 23; 11(6):881-886. PubMed ID: 26662658
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW, Tsao SM, Lai CL, Su CC, Tseng CE.
    Pathology; 2010 Apr 23; 42(3):224-8. PubMed ID: 20350214
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH, Chang JH.
    Chest; 2005 Oct 23; 128(4):2298-303. PubMed ID: 16236887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.